Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy
暂无分享,去创建一个
Steven H. Lin | A. Koong | Z. Liao | Aileen B Chen | S. Giordano | S. Frank | K. Liao | X. Lei | Grace L. Smith | Y. Shih | Vivek Verma | S. Shaaban | Sherif Shaaban | Percy Lee | Wayne L. Hoftstetter
[1] Haiyu Zhou,et al. Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) , 2020, EClinicalMedicine.
[2] P. Bondiau,et al. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China , 2020, BMC Cancer.
[3] Joe Y. Chang,et al. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] James B. Yu,et al. Proton-Based Chemoradiotherapy-What Level of Evidence Is Necessary to Justify Its Widespread Use? , 2019, JAMA oncology.
[5] J. Metz,et al. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. , 2019, JAMA oncology.
[6] O. Ciani,et al. Measuring Value in Health Care: A Comparative Analysis of Value-based Frameworks. , 2019, Clinical therapeutics.
[7] W. Harmsen,et al. A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiotherapy for Esophageal Cancer. , 2019, Practical radiation oncology.
[8] A. Gray,et al. A systematic review of health economic evaluations of proton beam therapy for adult cancer: Appraising methodology and quality , 2019, Clinical and translational radiation oncology.
[9] J. Thacker. Overview of Enhanced Recovery After Surgery: The Evolution and Adoption of Enhanced Recovery After Surgery in North America. , 2018, The Surgical clinics of North America.
[10] O. Ljungqvist,et al. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations , 2018, World Journal of Surgery.
[11] R. van Hillegersberg,et al. Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer. , 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[12] S. McGovern,et al. Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] L. Schuchter,et al. Best Practices for Reducing Unplanned Acute Care for Patients With Cancer. , 2018, Journal of oncology practice.
[14] C. Simone,et al. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review , 2018, Journal of the National Cancer Institute.
[15] Jinzhong Yang,et al. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] P. Thall,et al. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. , 2017, Radiotherapy and Oncology.
[17] Reshma Jagsi,et al. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. , 2017, International journal of radiation oncology, biology, physics.
[18] M. Mehta,et al. A systematic review of the cost and cost‐effectiveness studies of proton radiotherapy , 2016, Cancer.
[19] Steven H. Lin,et al. Improving Outcomes for Esophageal Cancer using Proton Beam Therapy. , 2016, International journal of radiation oncology, biology, physics.
[20] E. Steyerberg,et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. , 2015, The Lancet. Oncology.
[21] B. Mungo,et al. Incidence and risk factors for respiratory complications in patients undergoing esophagectomy for malignancy: a NSQIP analysis. , 2014, Seminars in thoracic and cardiovascular surgery.
[22] M. Steinberg,et al. Value: a framework for radiation oncology. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] G. Hospers,et al. Impact of Neoadjuvant Chemoradiotherapy on Postoperative Course after Curative-intent Transthoracic Esophagectomy in Esophageal Cancer Patients , 2014, Annals of Surgical Oncology.
[24] J. Michalski,et al. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma , 2013, Cancer.
[25] J. Ajani,et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer. , 2013, International journal of radiation oncology, biology, physics.
[26] Y. Lievens,et al. Health economic controversy and cost-effectiveness of proton therapy. , 2013, Seminars in radiation oncology.
[27] E W Steyerberg,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.
[28] Anthony O'Hagan,et al. Review of Statistical Methods for Analysing Healthcare Resources and Costs , 2010, Health economics.
[29] Philippe Lambin,et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] S. Ramsey,et al. How should we define value in cancer care? , 2010, The oncologist.
[31] Radhe Mohan,et al. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. , 2008, International journal of radiation oncology, biology, physics.
[32] J Lyle Bootman,et al. Value in health care. , 2006, Managed care interface.